摘要
背景:由于缺乏早期诊断的生物标志物,阿尔茨海默氏病(AD)很难诊断。早期的AD患者,视觉下降皮质神经退行性疾病有关是公认的,但最近的研究已经表明,比起脆弱的大脑区域,如皮质和海马,视网膜可能更容易受到影响。在这篇综述中,我们讨论了研究结果,这些研究表明视网膜的功能改变可能成为最早的诊断AD的生物标志物。 方法:通过关注于主题,对同行评审的研究文献的书目数据库进行分析,使用标准的包含/排除法,即视网膜突触功能障碍与大脑回忆变化有关。 结果:共有134篇论文被纳入研究,大多数(52)与处理最早的突触功能障碍和脆弱脑区的神经网络有关,并指出他们如何可能激发视网膜的类似研究。在随后的40和31篇论文的分析的基础上,分别讨论了AD晚期患者的视网膜组织和视网膜改变。最后,我们提出了证据(11篇论文),并表明通过使用现代成像和功能技术和非侵入性的的检测,视网膜突触功能障碍成为最早诊断AD的潜力。
关键词: 阿尔茨海默病,淀粉样蛋白斑块,胶质细胞活化,神经退行性疾病,阿尔茨海默病,淀粉样蛋白斑块,胶质细胞活化,神经退行性变,tau蛋白
Current Alzheimer Research
Title:Seeing Early Signs of Alzheimer's Disease Through the Lens of the Eye
Volume: 14 Issue: 1
Author(s): Brian T. Reed, Francine Behar-Cohen, Slavica Krantic
Affiliation:
关键词: 阿尔茨海默病,淀粉样蛋白斑块,胶质细胞活化,神经退行性疾病,阿尔茨海默病,淀粉样蛋白斑块,胶质细胞活化,神经退行性变,tau蛋白
摘要: Background: Alzheimer's disease (AD) develops undetected for years due to the lack of early diagnostic biomarkers. In advanced AD, visual deficits related to cortical neurodegeneration are well recognized, but recent studies have identified that the retina could be affected prior to vulnerable brain areas such as cortex and hippocampus. In this review, we discuss a new evidence suggesting that functional alterations in the retina may become the earliest diagnostic biomarkers for AD.
Methods: Analytical analysis of bibliographic databases for peer-reviewed research literature was performed by focusing on the review topic and using standard inclusion/exclusion criteria in the context of the given conceptual framework i.e., that synaptic dysfunction within the retina may be reminiscent of changes within the brain. Results: A total of 134 papers were included in the review, the majority (52) dealing with the earliest dysfunction of synaptic and neuronal networks in vulnerable brain areas to point out how they may inspire the analogous research in the retina. The general aspects of retina organization and the retinal alterations in the late stages of AD are then discussed based on the analysis of the next 40 and 31 papers, respectively. We finally present evidence (11 papers) indicating why putative retinal synaptic dysfunction holds the potential to become the earliest sign of AD, allowing for a non-invasive and easy detection using modern imaging and functional techniques. Conclusion: Translation of these findings to clinical diagnosis could lead to earlier therapeutic interventions and, consequently, better chances to delay or halt AD progression.Export Options
About this article
Cite this article as:
Brian T. Reed, Francine Behar-Cohen, Slavica Krantic , Seeing Early Signs of Alzheimer's Disease Through the Lens of the Eye, Current Alzheimer Research 2017; 14 (1) . https://dx.doi.org/10.2174/1567205013666160819131904
DOI https://dx.doi.org/10.2174/1567205013666160819131904 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
NMDA Receptor Antagonists as Antidepressant and Antidementia Drugs: Recent Developments and Future Prospects
Current Medicinal Chemistry - Central Nervous System Agents HIV-1, Methamphetamine and Astrocyte Glutamate Regulation: Combined Excitotoxic Implications for Neuro-AIDS
Current HIV Research An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry The Clinics and Etiology of Preeclampsia
Current Women`s Health Reviews Human Microdialysis
Current Pharmaceutical Biotechnology Pediatric Epilepsy Surgery: Neuropsychological and Psychosocial Outcomes
Current Pediatric Reviews Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Current Cardiology Reviews Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Current Pharmaceutical Design The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants
Current Drug Metabolism Brain-Derived Neurotrophic Factor and Antidepressant Activity
Current Pharmaceutical Design Clinical Profile of Mortality among Chronic Schizophrenic Patients: A Local Pilot Survey in Iran
Current Psychiatry Research and Reviews Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging
Current Medicinal Chemistry Diabetes Mellitus: Novel Insights, Analysis and Interpretation of Pathophysiology and Complications Management with Imidazole-Containing Peptidomimetic Antioxidants
Recent Patents on Drug Delivery & Formulation Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
Current Alzheimer Research <i>In Vivo</i> Longitudinal Monitoring of Changes in the Corpus Callosum Integrity During Disease Progression in a Mouse Model of Alzheimer’s Disease
Current Alzheimer Research Recent Advancements in Nanodiamond Mediated Brain Targeted Drug Delivery and Bioimaging of Brain Ailments: A Holistic Review
Pharmaceutical Nanotechnology Antiphospholipid Syndrome as a Neurological Disease
Current Rheumatology Reviews A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem
Current Pharmaceutical Biotechnology Interleukin-1β Plays a Role in the Activation of Peripheral Leukocytes after Blood-Brain Barrier Rupture in the Course of Subarachnoid Hemorrhage
Current Neurovascular Research